# The effect of chemotherapeutic agents on epidermal neural crest stem cells

**Authors:** Nasim Rahmani-Kukia, Fatemeh Keshavarzi, Mohammad Saied Salehi, Farzaneh Bozorg-Ghalati, Zahra Mojtahedi, Mozhdeh Zamani, Negar Azarpira, Pooneh Mokarram

PMC · DOI: 10.22099/mbrc.2024.49755.1948 · 2025-01-01

## TL;DR

This study examines how chemotherapy drugs affect the function and survival of epidermal neural crest stem cells.

## Contribution

The paper reveals how specific chemotherapeutic agents influence stress pathways and migration in hEPI-NCSCs.

## Key findings

- DTT activates autophagy and UPR pathways in hEPI-NCSCs, aiding cell survival.
- Salinomycin and Cisplatin inhibit NCSC migration and alter gene expression.
- 5-FU and Ebselen suppress autophagy and UPR, reducing NCSC function.

## Abstract

Human Epidermal Neural Crest Stem Cells (hEPI-NCSCs), as a transient population of multipotent migratory stem cells can differentiate into multiple types of neural and non-neural cells and tissues in the body. Here, we tried to determine the role of chemo agents in mediating the stress induced pathways like autophagy and unfolded protein responses (UPR), as well as the migratory potential of NCSCs. hEPI-NCSCs were treated with chemo agents including Dithiothreitol [(DTT) 10µM)], Salinomycin (9mM), Ebselen (10mM), 5-Fluorouracil [(5-FU) 8µM] and Cisplatin (6mM) for 72 hours. The reverse transcription-quantitative polymerase chain reaction (RT- qPCR) and scratch wound healing assays were used to assess the effect of chemo agents on NCSCs function. After treatment with DTT, hEPI-NCSCs upregulated the expression of genes related to autophagy and UPR pathways including LC3, P62 and CHOP. These genes were also overexpressed when NCSCs were treated with Salinomycin. Reverse results were verified by 5-FU, Ebselen and Cisplatin treatment. Salinomycin and Cisplatin upregulated the expression of XBP-1, which down regulated with DTT, 5-FU and Ebselen. Inhibition in migratory capacity of NCSCs was detected following treatment by Salinomycin, 5-FU, Ebselen and Cisplatin. DTT and 5-FU promoted the expression of BDNF, while Salinomycin, Cisplatin and Ebselen treatment reduced its expression. During exposition to DTT, the autophagy pathway was activated, implying that autophagy functions as a survival mechanism for deactivating the inhibitory effects of DTT on the migratory capacity of NCSCs. Chemotherapeutic agents like 5-FU and cisplatin exert cytotoxic effects on NCSCs by suppressing autophagy, UPR pathways, and the migratory potential of NCSCs.

## Linked entities

- **Genes:** MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557], GTF2H1 (general transcription factor IIH subunit 1) [NCBI Gene 2965], DDIT3 (DNA damage inducible transcript 3) [NCBI Gene 1649], XBP1 (X-box binding protein 1) [NCBI Gene 7494], BDNF (brain derived neurotrophic factor) [NCBI Gene 627]
- **Chemicals:** Dithiothreitol (PubChem CID 19001), Salinomycin (PubChem CID 3085092), Ebselen (PubChem CID 3194), 5-Fluorouracil (PubChem CID 3385), Cisplatin (PubChem CID 5460033)

## Full-text entities

- **Genes:** DDIT3 (DNA damage inducible transcript 3) [NCBI Gene 1649] {aka AltDDIT3, C/EBPzeta, CEBPZ, CHOP, CHOP-10, CHOP10}, NUP62 (nucleoporin 62) [NCBI Gene 23636] {aka IBSN, SNDI, p62}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557] {aka ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3}, XBP1 (X-box binding protein 1) [NCBI Gene 7494] {aka TREB-5, TREB5, XBP-1, XBP2}
- **Diseases:** cytotoxic (MESH:D064420)
- **Chemicals:** 5-FU (MESH:D005472), Cisplatin (MESH:D002945), hEPI (MESH:C058188), Ebselen (MESH:C042986), DTT (MESH:D004229), Salinomycin (MESH:C010327)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11865930/full.md

---
Source: https://tomesphere.com/paper/PMC11865930